tratado_fibro_quistica

94 INFLAMACIÓN DE LA VÍA AÉREA
62. Lands LC, Milner R, Cantin AM, Manson D,
Corey M. High-dose ibuprofen in cystic fibrosis:
Canadian safety and effectiveness
trial. J Pediatr. 2007;151(3):249-54.
63. Koyama H, Geddes DM. Erythromycin
and diffuse panbronchiolitis. Thorax.
1997;52(10):915-8.
64. Kudoh S, Azuma A, Yamamoto M, Izumi T,
Ando M. Improvement of survival in patients
with diffuse panbronchiolitis treated with
low-dose erythromycin. Am J Respir Crit
Care Med. 1998;157(6 Pt 1):1829-32.
65. Verleden GM, Vanaudenaerde BM, Dupont
LJ, Van Raemdonck DE. Azithromycin
reduces airway neutrophilia and interleukin-8
in patients with bronchiolitis obliterans
syndrome. Am J Respir Crit Care Med.
2006;174(5):566-70.
66. Tsai WC, Rodriguez ML, Young KS, Deng JC,
Thannickal VJ, Tateda K, et al. Azithromycin
blocks neutrophil recruitment in Pseudomonas
endobronchial infection. Am J Respir Crit
Care Med. 2004;170(12):1331-9.
67. Saiman L, Marshall BC, Mayer-Hamblett
N, Burns JL, Quittner AL, Cibene DA, et al.
Azithromycin in patients with cystic fibrosis
chronically infected with Pseudomonas aeruginosa:
a randomized controlled trial. JAMA.
2003;290(13):1749-56.
68. Peckham DG. Macrolide antibiotics and cystic
fibrosis. Thorax. 2002;57(3):189-90.
69. Saiman L, Anstead M, Mayer-Hamblett N,
Lands LC, Kloster M, Hocevar-Trnka J, et al.
Effect of azithromycin on pulmonary function
in patients with cystic fibrosis uninfected with
Pseudomonas aeruginosa: a randomized controlled
trial. JAMA. 2010;303(17):1707-15.
70. Tramper-Stranders GA, Wolfs TF, Fleer A,
Kimpen JL, van der Ent CK. Maintenance azithromycin
treatment in pediatric patients with
cystic fibrosis: long-term outcomes related to
macrolide resistance and pulmonary function.
Pediatr Infect Dis J. 2007;26(1):8-12.
71. Downey DG, Brockbank S, Martin SL, Ennis M,
Elborn JS. The effect of treatment of cystic
fibrosis pulmonary exacerbations on airways
and systemic inflammation. Pediatr Pulmonol.
2007;42(8):729-35.
72. Tepper RS, Eigen H, Stevens J, Angelicchio C, Kisling
J, Ambrosius W, et al. Lower respiratory illness
in infants and young children with cystic fibrosis:
evaluation of treatment with intravenous hydrocortisone.
Pediatr Pulmonol. 1997;24(1):48-51.
73. Davies L, Angus RM, Calverley PM. Oral corticosteroids
in patients admitted to hospital with
exacerbations of chronic obstructive pulmonary
disease: a prospective randomised controlled
trial. Lancet. 1999;354(9177):456-60.
74. Dovey M, Aitken ML, Emerson J, McNamara
S, Waltz DA, Gibson RL. Oral corticosteroid
therapy in cystic fibrosis patients hospitalized
for pulmonary exacerbation: a pilot study.
Chest.2007;132(4):1212-8.
75. Ghdifan S, Couderc L, Michelet I, Leguillon C,
Masseline B, Marguet C. Bolus methylprednisolone
efficacy for uncontrolled exacerbation
of cystic fibrosis in children. Pediatrics.
2010;125(5):e1259-64.